Nomura Holdings
TMBR

Nomura Holdings’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Nomura Holdings’s Portfolio TMBR Stock Details TMBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1
Closed -$16K – 2108
2015
Q4 		$16K Buy
+1
New +$18.9K ﹤0.01% 1804

Other funds holding TMBR

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Nomura Holdings's TMBR Position: Q1 2016 in Review

Nomura Holdings sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q1 2016, closing a stake of 1 share — an estimated $16K sold.

Nomura Holdings first reported a position in TMBR in Q4 2015 and held it in 1 quarter. The position peaked at $16K in Q4 2015. 10 funds tracked by Wall St. Rank hold TMBR as of Q1 2016.

  • Nomura Holdings reported no remaining Timber Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Nomura Holdings sold 1 Timber Pharmaceuticals, Inc. share in Q1 2016, an estimated $16K.
  • Nomura Holdings first reported a position in Timber Pharmaceuticals, Inc. in Q4 2015 and held it in 1 quarter.
  • Nomura Holdings's Timber Pharmaceuticals, Inc. position peaked at $16K in Q4 2015.
  • 10 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q1 2016.

Based on Nomura Holdings's 13F filing for Q1 2016, filed 16 May 2016.